Prolonged survival in advanced squamous cell lung carcinoma by rational and standardized treatment: A case report of long‐term survival in a patient with NSCLC
Abstract Objective To report the treatment of a long‐term survival case of stage IV lung squamous cell carcinoma (LSCC) patient with multiorgan metastases, including intrapulmonary, brain, liver, bone, and multiple lymph nodes. Methods and results A 72‐year‐old male patient with stage IV LSCC achiev...
Main Authors: | Min Ji, Yue Shi, Renrui Zou, Yingying Jiang, Li Wang, Rong Ma, Xiuming Zhang, Xiangzhi Zhu, Cheng Chen, Meiqi Shi, Xiaohua Wang, Jifeng Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Precision Medical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1002/prm2.12035 |
Similar Items
-
Cost-Effectiveness of Pembrolizumab Plus Chemotherapy Versus Pembrolizumab Monotherapy in Metastatic Non-Squamous and Squamous NSCLC Patients With PD-L1 Expression ≥ 50%
by: Qiao Liu, et al.
Published: (2022-01-01) -
Promising targets and current clinical trials in metastatic non-squamous NSCLC
by: Alona eZer, et al.
Published: (2014-11-01) -
The Impact of the Availability of Immunotherapy on Patterns of Care in Stage III NSCLC: A Dutch Multicenter Analysis
by: Merle I. Ronden, MD, et al.
Published: (2021-07-01) -
Isolation of <i>Pseudomonas oleovorans</i> Carrying Multidrug Resistance Proteins MdtA and MdtB from Wastewater
by: Haifeng Wang, et al.
Published: (2023-07-01) -
A clinical variable‐based nomogram could predict the survival for advanced NSCLC patients receiving second‐line atezolizumab
by: Xiaoling Shang, et al.
Published: (2021-09-01)